Delivery systems for delivering functional compounds to substrates and processes of using the same

US9283188B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9283188-B2
Application numberUS-53021006-A
CountryUS
Kind codeB2
Filing dateSep 8, 2006
Priority dateSep 8, 2006
Publication dateMar 15, 2016
Grant dateMar 15, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Delivery systems for incorporating functional compounds into substrates for use in various consumer products are disclosed. Specifically, the delivery system includes a carrier component comprising an ultrasonically energized adsorbent and one or more functional compounds. The ultrasonically energized adsorbent can adsorb the desired functional compounds and bind the functional compounds to the surface of the substrate.

First claim

Opening claim text (preview).

What is claimed is: 1. A process of delivering functional compounds to a substrate, the process comprising: energizing an adsorbent with ultrasonic energy using an ultrasonic treatment system comprising an inlet end, an outlet end, and an ultrasonic waveguide assembly, wherein the ultrasonic waveguide assembly is a horn assembly comprising a horn member comprising two or more agitating members connected to the horn member and extending at least in part transversely outward from the outer surface of the horn member in longitudinally spaced relationship with each other, the agitating members and the horn member being constructed and arranged for dynamic motion of the agitating members relative to the horn member upon ultrasonic vibration of the horn member such to create a nodal region of the horn member; wherein the adsorbent is selected from the group consisting of alumina, silica, activated carbon, zeolites and combinations thereof; wherein the ultrasonic energy is produced by the ultrasonic waveguide assembly that is ultrasonically excited at a frequency of from about 15,000 Hz to about 100,000 Hz; introducing a fluid comprising at least one functional compound through the inlet end at a flow rate of from about 100 ml/min to about 20 L/min; wherein the at least one functional compound is selected from the group consisting of pharmaceuticals, xenobiotics, therapeutic agents, nutritional agents, anti-viral agents, anti-microbial agents, UV absorbers, signal agents, and combinations thereof; wherein the fluid is at a temperature of from about 20° C. to about 90° C. and has a pH of from about 2.0 to about 10.0; adsorbing the at least one functional compound to the surface of the energized adsorbent to form a carrier component of a delivery system, wherein the adsorbing step is conducted for a period of from about 10 seconds to about 10 minutes; removing the carrier component through the outlet end; wherein the pressure within the ultrasonic treatment system is from about 1 psi to about 10 psi; and contacting the carrier component with a substrate; wherein the substrate is selected from the group consisting of a product comprising a polyolefin polymer, the skin of a human or animal, and tissue inside a body of a human or animal. 2. The process as set forth in claim 1 wherein the adsorbent is alumina, the alumina being in the form of a particle selected from the group consisting of alumina particles and alumina covered particles. 3. The process as set forth in claim 2 wherein the particles have a particle size of from about 5 nanometers to less than 500 microns. 4. The process as set forth in claim 1 wherein the ultrasonic energy is produced by the ultrasonic waveguide assembly that is ultrasonically excited at a frequency of from about 20,000 Hz to about 40,000 Hz. 5. The process as set forth in claim 1 wherein the horn member is an elongated cylindrical horn member. 6. The process as set forth in claim 1 wherein the ultrasonic treatment system is a continuous ultrasonic treatment system. 7. The process as set forth in claim 6 wherein the ultrasonic treatment system further comprises an ultrasonic treatment chamber enclosing the horn member. 8. The process as set forth in claim 1 wherein the adsorbing step takes place in a batch process. 9. The process as set forth in claim 1 wherein the adsorbing step is conducted for a period of from about 5 minutes to about 10 minutes. 10. The process as set forth in claim 1 wherein the substrate is a woven or non-woven material made from a polyolefin polymer. 11. The process as set forth in claim 10 further comprising pre-treating the substrate prior to contacting the carrier component with the substrate. 12. The process as set forth in claim 10 further comprising post-treating the substrate subsequent to contacting the carrier component with the substrate. 13. The process as set forth in claim 1 wherein the substrate is tissue inside of the body of a patient. 14. The process as set forth in claim 1 wherein the functional compound is selected from the group consisting of pharmaceuticals and signal agents. 15. The process as set forth in claim 1 wherein the functional compound is selected from the group consisting of hydrocortisone, tetracycline, salicylanilide, albofungin, an anthraquinone dye, baicalin hydrate, baicalein, daunorubicin, salicylamide, salacetamide, salsalate, ascorbic acid, aspartame, salicylaldehyde and a UV absorber.

Assignees

Inventors

Classifications

  • Skin, i.e. galenical aspects of topical compositions (non-active ingredients are additionally classified in A61K47/00; A61K9/0009, A61K9/0021, A61K9/7015, A61K9/7023 take precedence; cosmetic preparations A61K8/00, A61Q; preparations for wound dressings or bandages A61L26/00) · CPC title

  • Aluminium, calcium or magnesium; Compounds thereof {, e.g. clay} · CPC title

  • Silicon; Compounds thereof · CPC title

  • A61K9/143Primary

    with inorganic compounds · CPC title

  • Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9283188B2 cover?
Delivery systems for incorporating functional compounds into substrates for use in various consumer products are disclosed. Specifically, the delivery system includes a carrier component comprising an ultrasonically energized adsorbent and one or more functional compounds. The ultrasonically energized adsorbent can adsorb the desired functional compounds and bind the functional compounds to the…
Who is the assignee on this patent?
Janssen Robert Allen, Mccraw Jr Earl C, Thompson Kimberlee Fay, and 4 more
What technology area does this patent fall under?
Primary CPC classification A61K9/143. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Mar 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).